Human hepatitis B virus X protein promotes cell proliferation and inhibits cell apoptosis through interacting with a serine protease Hepsin

Archives of Virology

Volumn 150, Issue 4, 2005, Pages 721-741

  Zhang, J L ^a   Zhao, W G ^a   Wu, K L ^a   Wang, K ^a   Zhang, X ^a   Gu, C F ^a   Li, Y ^a   Zhu, Y ^a   Wu, J G ^a  

^a WUHAN UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS B ANTIGEN; HEPATITIS B VIRUS X PROTEIN; HEPSIN; MEMBRANE PROTEIN; PRIMER DNA; SERINE PROTEINASE; TRANSACTIVATOR PROTEIN;

APOPTOSIS; ARTICLE; CELL DIVISION; CELL LINE; DRUG EFFECT; HUMAN; LIVER; LIVER CELL CARCINOMA; LIVER TUMOR; METABOLISM; NUCLEOTIDE SEQUENCE; PATHOLOGY; TUMOR CELL LINE;

APOPTOSIS; BASE SEQUENCE; CARCINOMA, HEPATOCELLULAR; CELL DIVISION; CELL LINE; CELL LINE, TUMOR; DNA PRIMERS; HEPATITIS B ANTIGENS; HUMANS; LIVER; LIVER NEOPLASMS; MEMBRANE PROTEINS; SERINE ENDOPEPTIDASES; TRANS-ACTIVATORS;

HEPATITIS B VIRUS;

EID: 17644383750     PISSN: 03048608     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00705-004-0446-0     Document Type: Article

References (43)

1. Feitelson MA, Duan LX (1997) Hepatitis B virus X antigen in the pathogenesis of chronic infections and the development of hepatocellular carcinoma. Am J Path 150(4): 1141-1157
2. Chen HS, Kaneko S, Girones R, Anderson RW, Hornbuckle WE, Tennant BC, Cote PJ, Gerin JL, Purcell RH, Miller RH (1993) The woodchuck hepatitis virus X gene is important for establishment of virus infection in woodchucks. J Virol 67: 1218-1226
3. Koike K, Moriya K, Yotsuyanagi H, Iino S, Kurokawa K (1994) Induction of cell cycle progression by hepatitis B virus HBx gene expression in quiescent mouse fibroblasts. J Clin Invest 94(1): 44-49
4. Kim CM, Koike K, Saito I, Miyamura T, Jay G (1991) HBx gene of hepatitis B virus induces liver cancer in transgenic mice. Nature 351(6324): 317-320
5. Terradillos O, Billet O, Renard CA, Levy R, Molina T, Briand P, Buendia MA (1997) The hepatitis B virus X gene potentiates c-myc-induced liver oncogenesis in transgenic mice. Oncogene 14(4): 395-404
6. Klein NP, Schneider RJ (1997) Activation of Src family kinases by hepatitis B virus HBx protein and coupled signaling to Ras. Mol Cell Biol 17(11): 6427-6436
7. Andrisani OM, Barnabas S (1999) The transcriptional function of the hepatitis B virus X protein and its role in hepatocarcinogenesis. Int J Oncol 15(2): 373-379
8. Diao J, Garces R, Richardson CD (2001) X protein of hepatitis B virus modulates cytokine and growth factor related signal transduction pathways during the course of viral infections and hepatocarcinogenesis. Cytokine Growth Factor Rev 12(2-3): 189-205
9. Benn J, Schneider RJ (1994) Hepatitis B virus HBx protein activates Ras-GTP complex formation and establishes a Ras, Raf, MAP kinase signaling cascade. Proc Natl Acad Sci USA 91(22): 10350-10354
10. Tarn C, Lee S, Hu Y, Ashendel C, Andrisani OM (2001) Hepatitis B virus X protein differentially activates RAS-RAF-MAPK and JNK pathways in X-transforming versus non-transforming AML12 hepatocytes. J Biol Chem 276(37): 34671-34680
11. Weil R, Sirma H, Giannini C, Kremsdorf D, Bessia C, Dargemont C (1999) Direct association and nuclear import of the hepatitis B virus X protein with the NF-kappaB inhibitor IkappaBalpha. Mol Cell Biol 19(9): 6345-6354
12. Haviv I, Vaizel D, Shaul Y (1996) pX, the HBV-encoded coactivator, interacts with components of the transcription machinery and stimulates transcription in a TAF-independent manner. EMBO J 15(13): 3413-3420
13. Lin Y, Nomura T, Cheong J, Dorjsuren D, Iida K, Murakami S (1997) Hepatitis B virus X protein is a transcriptional modulator that communicates with transcription factor IIB and the RNA polymerase II subunit 5. J Biol Chem 272(11): 7132-7139
14. Haviv I, Shamay M, Doitsh G, Shaul Y (1998) Hepatitis B virus pX targets TFIIB in transcription coactivation. Mol Cell Biol 18(3): 1562-1569
15. Ueda H, Ullrich SJ, Gangemi JD, Kappel CA, Ngo L, Feitelson MA, Jay G (1995) Functional inactivation but not structural mutation of p53 causes liver cancer. Nat Genet 9(1): 41-17
16. Sitterlin D, Lee TH, Prigent S, Tiollais P, Butel JS, Transy C (1997) Interaction of the UV-damaged DNA-binding protein with hepatitis B virus X protein is conserved among mammalian hepadnaviruses and restricted to transactivation-proficient X-insertion mutants. J Virol 71(8): 6194-6199
17. Wang XW, Forrester K, Yeh H, Feitelson MA, Gu JR, Harris CC (1994) Hepatitis B virus X protein inhibits p53 sequence-specific DNA binding, transcriptional activity, and association with transcription factor ERCC3. Proc Natl Acad Sci USA 91(6): 2230-2234
18. Forgues M, Marrogi AJ, Spillare EA, Wu CG, Yang Q, Yoshida M, Wang XW (2001) Interaction of the hepatitis B virus X protein with the Crm1-dependent nuclear export pathway. J Biol Chem 276(25): 22797-22803
19. Sun BS, Zhu X, Clayton MM, Pan J, Feitelson MA (1998) Identification of a protein isolated from senescent human cells that binds to hepatitis B virus X antigen. Hepatology 27(1): 228-239
20. Elmore LW, Hancock AR, Chang SF, Wang XW, Chang S, Callahan CP, Geller DA, Will H, Harris CC (1997) Hepatitis B virus X protein and p53 tumor suppressor interactions in the modulation of apoptosis. Proc Natl Acad Sci USA 94(26): 14707-14712
21. Pan J, Duan LX, Sun BS, Feitelson MA (2001) Hepatitis B virus X protein protects against anti-Fas-mediumed apoptosis in human liver cells by inducing NF-kappaB. J Gen Virol 82(Pt 1): 171-182
22. Shih WL, Kuo ML, Chuang SE, Cheng AL, Doong SL (2000) Hepatitis B virus X protein inhibits transforming growth factor-beta-induced apoptosis through the activation of phosphatidylinositol 3-kinase pathway. J Biol Chem 275(33): 25858-25864
23. Gottlob K, Fulco M, Levrero M, Graessmann A (1998) The hepatitis B virus HBx protein inhibits caspase 3 activity. J Biol Chem 273(50): 33347-33353
24. Bergametti F, Prigent S, Luber B, Benoit A, Tiollais P, Sarasin A, Transy C (1999) The proapoptotic effect of hepatitis B virus HBx protein correlates with its transactivation activity in stably transfected cell lines. Oncogene 18(18): 2860-2871
25. Sirma H, Giannini C, Poussin K, Paterlini P, Kremsdorf D, Brechot C (1999) Hepatitis B virus X mutants, present in hepatocellular carcinoma tissue abrogate both the antiproliferative and transactivation effects of HBx. Oncogene 18(34): 4848-1859
26. Koike K, Moriya K, Yotsuyanagi H, Shintani Y, Fujie H, Tsutsumi T, Kimura S (1998) Compensatory apoptosis in preneoplastic liver of a transgenic mouse model for viral hepatocarcinogenesis. Cancer Lett 134(2): 181-186
27. Dandri M, Petersen J, Stockert RJ, Harris TM, Rogler CE (1998) Metabolic labeling of woodchuck hepatitis B virus X protein in naturally infected hepatocytes reveals a bimodal half-life and association with the nuclear framework. J Virol 72(11): 9359-9364
28. Poussin K, Dienes H, Sirma H, Urban S, Beaugrand M, Franco D, Schirmacher P, Brechot C, Paterlini Brechot P (1999) Expression of mutated hepatitis B virus X genes in human hepatocellular carcinomas. Int J Cancer 80(4): 497-505
29. Su Q, Schroder CH, Hofmann WJ, Otto G, Pichlmayr R, Bannasch P (1998) Expression of hepatitis B virus X protein in HBV-infected human livers and hepatocellular carcinomas. Hepatology 27(4): 1109-1120
30. Chisari FV (2000) Rous-Whipple Award Lecture. Viruses, immunity, and cancer: lesion from hepatitis B. Am J Pathol 156: 1117-1132
31. Hooper JD, Clements JA, Quigley JP, Antalis TM (2001) Type II transmembrane serine proteases insights into an emerging class of cell surface proteolytic enzymes. J Biol Chem 276: 857-860
32. Tanimoto HY, Yan Y, Clark J, Korourian S, Shigemasa K, Parmley TH, Parham GB, O'Brien TJ (1997) Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer. Cancer Res 57: 2884-2887
33. Magee JA, Araki T, Patil S, Ehrig T, True L, Humphrey PA, Catalina WJ, Watson MA, Milbrandt J (2001) Expression profiling reveals Hepsin overexpression in prostate cancer. Cancer Res 61: 5692-5696
34. Dhanasekaran SM, Barrette TR, Ghosh D, Shah R, Varambally S, Kurachi K, Pienta KJ, Rubin MA, Chinnaiyan AM (2001 ) Delineation of prognostic biomarkers in prostate cancer. Nature 412: 822-826
35. Torres-Rosado A, O'Shea SK, Tsuji A, Chou SH, Kurachi K (1993) Hepsin, a putative cell-surface serine protease, is required for mammalian cell growth. Proc Natl Acad Sci USA 90: 7181-7185
36. Vu T-K, Liu RW, Haakasma CJ, Tomasek JJ, Howard EW (1997) Identification and cloning of the membrane-associated serine protease, Hepsin, from mouse preimplantation embryos. J Biol Chem 272: 31315-31320
37. Kazuma Y, Hamamoto T, Foster DC, Kisiel W (1995) Hepsin, a putative membrane-associated serine protease, activates human factor VII and initiates a pathway of blood coagulation on the cell surface leading to thrombin formation. J Biol Chem 270: 66-72
38. Wu Q, Yu D, Post J, Halks-Miller M, Evan Sadler J, Morser J (1998) Generation and characterization of mice deficient in Hepsin, a hepatic transmembrane serine protease. J Clin Investig 101: 321-326
39. Hasegawa I, Tanaka Y, Kramvis A, Kato T, Sugauchi F, Acharya SK, Orito E, Ueda R, Kew MC, Mizokami M (2004) Novel hepatitis B virus genotype a subtyping assay that distinguishes subtype Aa from Ae and its application in epidemiological studies. J Virol 78(14): 7575-7581
40. Sugauchi F, Kumada H, Acharya SA, Shrestha SM, Gamutan MT, Khan M, Gish RG, Tanaka Y, Kato T, Orito E, Ueda R, Miyakawa Y, Mizokami M (2004) Epidemiological and sequence differences between two subtypes (Ae and Aa) of hepatitis B virus genotype A. J Gen Virol 85: 811-820
41. Fields S, Song OK (1989) A novel genetic system to detect protein-protein interactions. Nature 340: 245-246
42. Tsuji A, Torres-Rosado A, Arai T, Le Beau MM, Lemons RS, Chou SH, Kurachi K (1991) Hepsin, a cell membrane-associated protease, Characterization, tissue distribution, and gene localization. J Biol Chem 266(25): 16948-16953
43. Brooks JD (2002) Microarray analysis in prostate cancer research. Curr Opin Urol 12(5): 395-399